Literature DB >> 10373532

p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells.

I Unnikrishnan1, A Radfar, J Jenab-Wolcott, N Rosenberg.   

Abstract

Transformation of pre-B cells by Abelson murine leukemia virus (Ab-MLV) involves a balance between positive, growth-stimulatory signals from the v-Abl oncoprotein and negative regulatory cues from cellular genes. This phenomenon is reflected by the clonal selection that occurs during Ab-MLV-mediated transformation in vivo and in vitro. About 50% of all Ab-MLV-transformed pre-B cells express mutant forms of p53 as they emerge from this process, suggesting that this protein may play an important role in the transformation process. Consistent with this idea, expression of p19(Arf), a protein whose function depends on the presence of a functional p53, is required for the apoptotic crisis that characterizes primary Ab-MLV transformants. To test the role of p53 in pre-B-cell transformation directly, we examined the response of Trp53(-/-) mice to Ab-MLV. The absence of p53 shortens the latency of Abelson disease induction but does not affect the frequency of cells susceptible to Ab-MLV-induced transformation. However, primary transformants derived from the null animals bypass the apoptotic crisis that characterizes the transition from primary transformant to fully malignant cell line. These effects do not require p21(Cip-1), a major downstream target of p53; however, consistent with a role of p19(Arf), transformants expressing mutant p53 and abundant p19 retain wild-type p19 sequences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373532      PMCID: PMC84281          DOI: 10.1128/MCB.19.7.4825

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

Authors:  S Zhang; E S Ramsay; B A Mock
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

3.  Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.

Authors:  A Engelman; N Rosenberg
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.

Authors:  P L Green; D A Kaehler; L M Bennett; R Risser
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

7.  Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.

Authors:  C A Whitlock; O N Witte
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

8.  Different genes control the susceptibility of mice to Moloney or Abelson murine leukemia viruses.

Authors:  R Risser; D Kaehler; W W Lamph
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.

Authors:  C A Whitlock; S F Ziegler; O N Witte
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

10.  A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

3.  Inhibition of TFII-I-dependent cell cycle regulation by p53.

Authors:  Zana P Desgranges; Jinwoo Ahn; Maria B Lazebnik; Todd Ashworth; Caleb Lee; Richard C Pestell; Naomi Rosenberg; Carol Prives; Ananda L Roy
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.

Authors:  X Zou; F Cong; M Coutts; G Cattoretti; S P Goff; K Calame
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.

Authors:  T Portis; W J Grossman; J C Harding; J L Hess; L Ratner
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.

Authors:  Erica Marchlik; Richard Kalman; Naomi Rosenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.

Authors:  Yukio Nakamura; Raelene J Grumont; Steve Gerondakis
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.

Authors:  C A Mainville; K Parmar; I Unnikrishnan; L Gong; G D Raffel; N Rosenberg
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.

Authors:  Rebekah Stackpole Zimmerman; Naomi Rosenberg
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

10.  Absence of p53 complements defects in Abelson murine leukemia virus signaling.

Authors:  Indira Unnikrishnan; Naomi Rosenberg
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.